<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" open-status="O" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-archivearticle1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4069071</article-id><article-id pub-id-type="pmid">24959929</article-id><article-id pub-id-type="publisher-id">PONE-D-14-00758</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0100388</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and Life Sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genetics of Disease</subject></subj-group></subj-group><subj-group><subject>Microbiology</subject><subj-group><subject>Virology</subject><subj-group><subject>Viral Disease Diagnosis</subject></subj-group></subj-group></subj-group><subj-group><subject>Population Biology</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine and Health Sciences</subject><subj-group><subject>Epidemiology</subject><subj-group><subject>Epidemiological Methods and Statistics</subject><subject>Genetic Epidemiology</subject><subject>Infectious Disease Epidemiology</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Research and Analysis Methods</subject><subj-group><subject>Research Design</subject><subj-group><subject>Survey Research</subject><subj-group><subject>Survey Methods</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="23880" pm="."><plain>Epidemiology and Viral Etiology of the Influenza-Like Illness in Corsica during the 2012–2013 Winter: An Analysis of Several Sentinel Surveillance Systems </plain></SENT>
</text></SecTag></article-title><alt-title alt-title-type="running-head">Surveillance of Influenza Like-Illness in Corsica</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Minodier</surname><given-names>Laëtitia</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Arena</surname><given-names>Christophe</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Heuze</surname><given-names>Guillaume</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ruello</surname><given-names>Marc</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Amoros</surname><given-names>Jean Pierre</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Souty</surname><given-names>Cécile</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref><xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Varesi</surname><given-names>Laurent</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Falchi</surname><given-names>Alessandra</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>EA7310, Laboratoire de Virologie, Université de Corse, Institut national de la Santé et de la Recherche Médicale, Corte, France</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Observatoire régional de la Santé de Corse, Ajaccio, France</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Cellule de l'Institut national de Veille Sanitaire en région, Ajaccio, France</addr-line>
</aff><aff id="aff4">
<label>4</label>
<addr-line>Sorbonne Universités Pierre et Marie Curie, Paris 06, UMRS 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France</addr-line>
</aff><aff id="aff5">
<label>5</label>
<addr-line>Institut national de la Santé et de la Recherche Médicale, UMRS 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Pyrc</surname><given-names>Krzysztof</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>Faculty of Biochemistry Biophysics and Biotechnology, Jagiellonian University, Poland</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>minodier@univ-corse.fr</email></corresp><fn fn-type="COI-statement"><p><text><SENT sid="23881" pm="."><plain>Competing Interests: The authors have declared that no competing interests exist. </plain></SENT>
</text></p></fn><fn fn-type="con"><p><text><SENT sid="23882" pm="."><plain>Conceived and designed the experiments: LM CA GH AF. </plain></SENT>
<SENT sid="23883" pm="."><plain>Performed the experiments: AF LM. </plain></SENT>
<SENT sid="23884" pm="."><plain>Analyzed the data: AF CA GH CS. </plain></SENT>
<SENT sid="23885" pm="."><plain>Contributed reagents/materials/analysis tools: JPA LV CS MR. </plain></SENT>
<SENT sid="23886" pm="."><plain>Wrote the paper: LM CA GH AF CS. </plain></SENT>
</text></p></fn></author-notes><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>24</day><month>6</month><year>2014</year></pub-date><volume>9</volume><issue>6</issue><elocation-id>e100388</elocation-id><history><date date-type="received"><day>17</day><month>1</month><year>2014</year></date><date date-type="accepted"><day>26</day><month>5</month><year>2014</year></date></history><permissions><copyright-statement>© 2014 Minodier et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Minodier et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="23887" pm="."><plain>Influenza-like illness (ILI) surveillance is important to identify circulating and emerging/reemerging strains and unusual epidemiological trends. </plain></SENT>
<SENT sid="23888" pm="."><plain>The present study aimed to give an accurate picture of the 2012–2013 ILI outbreak in Corsica by combining data from several surveillance systems: general practice, emergency general practice, hospital emergency units, intensive care units, and nursing homes. </plain></SENT>
<SENT sid="23889" pm="."><plain>Twenty-eight respiratory viruses were retrospectively investigated from patients in general practice with ILI. </plain></SENT>
<SENT sid="23890" pm="."><plain>Sequence analysis of the genetic changes in the hemagglutinin gene of influenza viruses (A(H1N1)pdm2009, A(H3N2) and B) was performed. </plain></SENT>
<SENT sid="23891" pm="."><plain>The trends in ILI/influenza consultation rates and the relative illness ratios (RIRs) of having an ILI consultation were estimated by age group for the different surveillance systems analyzed. </plain></SENT>
<SENT sid="23892" pm="."><plain>Of the 182 ILI patients enrolled by general practitioners, 57.7% tested positive for influenza viruses. </plain></SENT>
<SENT sid="23893" pm="."><plain>Phylogenetic analyses suggested a genetic drift for influenza B and A(H3N2) viruses. </plain></SENT>
<SENT sid="23894" pm="."><plain>The ILI/influenza surveillance systems showed similar trends and were well correlated. </plain></SENT>
<SENT sid="23895" pm="."><plain>In accordance with virological data, the RIRs of having an ILI consultation were highest among the young (&lt;15 years old) and decreased with age. </plain></SENT>
<SENT sid="23896" pm="."><plain>No clusters of acute respiratory illness were declared by the sentinel nursing homes. </plain></SENT>
<SENT sid="23897" pm="."><plain>This study is noteworthy in that it is the first extensive description of the 2012–2013 ILI outbreak in Corsica as monitored through several surveillance systems. </plain></SENT>
<SENT sid="23898" pm="."><plain>To improve ILI surveillance in Corsica, a consortium that links together the complementary regional surveillance ILI systems described here is being implemented. </plain></SENT>
</text></SecTag></p></abstract><funding-group><funding-statement>The research was supported by the Contrat Plan Etat Region 2007-2013 funding. All the funding or sources of support had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="13"/></counts></article-meta></front><body><SecTag type="INTRO"><sec id="s1"><title><text><SENT sid="23899" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="23900" pm="."><plain>The continuous circulation of influenza viruses in animal species carries the potential to cause severe human illness through cross-species transmission [1]. </plain></SENT>
<SENT sid="23901" pm="."><plain>It is also possible that virus adaptation to enable efficient and sustainable human-to-human transmission could possibly lead to worldwide pandemics [2]–[3]. </plain></SENT>
<SENT sid="23902" pm="."><plain>Past episodes have confirmed the need for supporting influenza surveillance networks throughout the world [4]–[5]. </plain></SENT>
</text></p><p><text><SENT sid="23903" pm="."><plain>The island of Corsica, a land bridge between Europe and Africa, is an important crossing area for infectious agents, which increases the public health importance of establishing an efficient and reliable surveillance system in the region. </plain></SENT>
</text></p><p><text><SENT sid="23904" pm="."><plain>In Corsica, the surveillance of disease, including influenza-like illness (ILI), is performed by several sentinel systems that are based on the activity of different health services: general practice, emergency general practice, hospital emergency units, intensive care units (ICUs), and nursing homes [6]–[8]. </plain></SENT>
</text></p><p><text><SENT sid="23905" pm="."><plain>ILI outbreaks have been described previously using virological and epidemiological data collected by general practitioners (GPs) of the Sentinelles network [9]–[10]. </plain></SENT>
<SENT sid="23906" pm="."><plain>The objective of this study was to describe the 2012–2013 ILI outbreak by combining the data from several surveillance systems that exist in Corsica. </plain></SENT>
<SENT sid="23907" pm="."><plain>The goal was to provide useful information on the 2012–2013 ILI outbreak in Corsica and to improve the overall coordination of the ILI surveillance system for subsequent ILI outbreaks. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="methods" id="s2"><title><text><SENT sid="23908" pm="."><plain>Methods </plain></SENT>
</text></title><sec id="s2a"><title><text><SENT sid="23909" pm="."><plain>Ethics </plain></SENT>
</text></title><p><text><SENT sid="23910" pm="."><plain>The protocol was conducted in accordance with the Helsinki Declaration. </plain></SENT>
<SENT sid="23911" pm="."><plain>All samples were coded and tested anonymously. </plain></SENT>
<SENT sid="23912" pm="."><plain>None of the authors collected samples. </plain></SENT>
<SENT sid="23913" pm="."><plain>Samples were collected and sent to authors by GPs involved in the virological surveillance. </plain></SENT>
<SENT sid="23914" pm="."><plain>Patient information was stored according to national regulations, and access to such data was restricted (permission CNIL 471393). </plain></SENT>
<SENT sid="23915" pm="."><plain>The patients' identities were not disclosed at any stage. </plain></SENT>
<SENT sid="23916" pm="."><plain>Oral consent was obtained from patients by the physician investigators. </plain></SENT>
<SENT sid="23917" pm="."><plain>For children under the age of 18, parents or legal guardians gave permission for their participation in surveillance. </plain></SENT>
<SENT sid="23918" pm="."><plain>Consent from the child was also obtained, depending on her or his age and maturity. </plain></SENT>
<SENT sid="23919" pm="."><plain>Based on French national laws (Law 1121-1-1° R. </plain></SENT>
<SENT sid="23920" pm="."><plain>1121-2), ethics committee approval and the written informed consent of patients are not required for specific microbiological diagnostic testing of the patients and further characterization of the infecting viruses. </plain></SENT>
</text></p></sec><sec id="s2b"><title><text><SENT sid="23921" pm="."><plain>The Corsican Sentinelles Network </plain></SENT>
</text></title><p><text><SENT sid="23922" pm="."><plain>The surveillance of ILIs is conducted in Corsica by five systems, described in detail below (Figure 1), the first of which is the Corsican Sentinelles network. </plain></SENT>
<SENT sid="23923" pm="."><plain>The GPs of the Corsican Sentinelles network participate in the nationwide continuous surveillance of the French Sentinelles network by reporting each week the number of new consultations for several health indicators, including ILIs [11]–[12]. </plain></SENT>
<SENT sid="23924" pm="."><plain>This system has been strengthened in Corsica since 2006–2007, and it currently includes 47 GPs throughout the island (16% of Corsican GPs). </plain></SENT>
<SENT sid="23925" pm="."><plain>Of these, 19 (40.4%) participated in the 2012–2013 virological surveillance of ILIs [9]. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0100388-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0100388.g001</object-id><label>Figure 1</label><caption><title><text><SENT sid="23926" pm="."><plain>Distribution of influenza-like illness surveillance networks in Corsica. </plain></SENT>
</text></title></caption><graphic xlink:href="pone.0100388.g001"/></fig></SecTag><p><text><SENT sid="23927" pm="."><plain>The Corsican Sentinelles network was the only network performing viral testing of ILIs in Corsica. </plain></SENT>
<SENT sid="23928" pm="."><plain>All the participating GPs received swabs and other study materials and were asked to enroll the first two patients of any age consulting a Sentinelles GP for an ILI in each week. </plain></SENT>
<SENT sid="23929" pm="."><plain>The Sentinelles network case definition used for the inclusion of ILI patients was a sudden fever of 39°C or above, and respiratory symptoms and myalgia [13] less than 48 hours after the onset of the symptoms. </plain></SENT>
<SENT sid="23930" pm="."><plain>Sample collection from patients with ILI was performed with Σ-Virocult® swabs (ELITech, France). </plain></SENT>
<SENT sid="23931" pm="."><plain>The nasopharyngeal swabs were sent by mail to the virological laboratory in 1 mL of viral transport medium and stored at −80°C. </plain></SENT>
<SENT sid="23932" pm="."><plain>Patient information, including demographic characteristics, symptoms, risk factors for severe influenza, treatment, vaccination status, and hospitalization, was documented in case report forms. </plain></SENT>
<SENT sid="23933" pm="."><plain>All samples were tested for influenza viruses A (A(H3N2) and A(H1N1)pdm2009) and B by influenza real-time reverse transcription–polymerase chain reaction (RT–PCR) (Table 1) [9]–[14]. </plain></SENT>
<SENT sid="23934" pm="."><plain>Samples were also tested for the simultaneous detection of 26 types/subtypes of respiratory viral pathogens using a Magicplex™ RV Panel Real-Time Test (Seegene) and as listed in Table 1. </plain></SENT>
<SENT sid="23935" pm="."><plain>Human rhinovirus (HRV) A/B/C, human respiratory syncytial virus A/B, and human metapneumovirus results were confirmed by a supplementary real-time RT–PCR [15]–[16]. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0100388-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0100388.t001</object-id><label>Table 1</label><caption><title><text><SENT sid="23936" pm="."><plain>Viral etiology of patients with influenza-like illness enrolled by the Corsican Sentinelles network. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0100388-t001-1" xlink:href="pone.0100388.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23937" pm="."><plain>Respiratory viruses </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="23938" pm="."><plain>Total % of 182 </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23939" pm="."><plain>Tested positive for at least one virus </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="23940" pm="."><plain>80.8 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23941" pm="."><plain>Single infection </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="23942" pm="."><plain>71.5 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23943" pm="."><plain>Co-infections </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="23944" pm="."><plain>9.3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23945" pm="."><plain>Influenza viruses in N patients </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23946" pm="."><plain>All Influenza viruses </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="23947" pm="."><plain>57.7 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23948" pm="."><plain>Influenza A* † </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="23949" pm="."><plain>27.5 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23950" pm="."><plain>Influenza A(H1N1)pdm2009 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="23951" pm="."><plain>18.1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23952" pm="."><plain>Influenza A(H3N2) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="23953" pm="."><plain>7.1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23954" pm="."><plain>Influenza B* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="23955" pm="."><plain>30.2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23956" pm="."><plain>Other respiratory viruses in N patients </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23957" pm="."><plain>Human Respiratory Syncytial virus (HRSV) A/B* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="23958" pm="."><plain>11.5 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23959" pm="."><plain>Human Rhinovirus (HRV) A/B/C/Human Enterovirus* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="23960" pm="."><plain>6.6 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23961" pm="."><plain>Human Adenovirus (HAdV) (A/B/C/D/E/F)* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="23962" pm="."><plain>6.0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23963" pm="."><plain>Human Coronavirus (HCoV) 229E/NL63/OC43* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="23964" pm="."><plain>4.0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23965" pm="."><plain>Human Bocavirus (HBoV) 1/2/3/4* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="23966" pm="."><plain>2.2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23967" pm="."><plain>Human Metapneumovirus (HMPV)* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="23968" pm="."><plain>1.6 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="23969" pm="."><plain>Human ParaInfluenzae (HPIV)1/2/3/4* </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="23970" pm="."><plain>0.5 </plain></SENT>
</text></td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p><text><SENT sid="23971" pm="."><plain>*Viruses detected by the Magiplex™ RV Panel Real-time test. </plain></SENT>
</text></p></fn><fn id="nt102"><label>†</label><p><text><SENT sid="23972" pm="."><plain>Four influenza A viruses have not been sub-typed. </plain></SENT>
</text></p></fn></table-wrap-foot></table-wrap></SecTag></sec><sec id="s2c"><title><text><SENT sid="23973" pm="."><plain>Nucleotide Sequencing and Phylogenetic Analysis of Influenza Viruses </plain></SENT>
</text></title><p><text><SENT sid="23974" pm="."><plain>The hemagglutinin (HA) sequences were amplified by RT–PCR using primer sets for human A(H3N2) (nucleic acids 48–1642), A(H1N1)pdm2009 (nucleic acids 73–1200), and B (nucleic acids 1–1742) influenza viruses [9],[17],[18]. </plain></SENT>
<SENT sid="23975" pm="."><plain>Double-stranded sequencing of the purified PCR products (primer sequences are available on request) was performed using an Applied Biosystems Sequencer (ABI 3700, Perkin-Elmer). </plain></SENT>
<SENT sid="23976" pm="."><plain>Phylogenetic trees were constructed using a Neighborg-Joining method based on Kimura's two-parameter genetic distances matrix with 1,000 bootstrap replicates (n = 1000) using the MEGA 5.0 program [19]. </plain></SENT>
<SENT sid="23977" pm="."><plain>The nucleotide sequence data from this study were deposited into GenBank at the National Center for Biotechnology Information (NCBI) (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov">http://www.ncbi.nlm.nih.gov</ext-link>) under the following accession numbers: KF928708–KF928726 for influenza B, KF928727–KF928744 for influenza A(H1N1)pdm2009, and KC814184–KC814214 for influenza A(H3N2). </plain></SENT>
</text></p></sec><sec id="s2d"><title><text><SENT sid="23978" pm="."><plain>The Emergency General Practice Network: SOS Médecins </plain></SENT>
</text></title><p><text><SENT sid="23979" pm="."><plain>The French Institute for Public Health Surveillance (Institut de Veille Sanitaire, InVS) developed in 2003 a syndromic surveillance system based on the activity of emergency health professionals through an organization called SOS Médecins, which is the first emergency network of GPs and health care in France [8]. </plain></SENT>
<SENT sid="23980" pm="."><plain>In Corsica, this emergency general practice surveillance system was implemented in December 2010. </plain></SENT>
<SENT sid="23981" pm="."><plain>It is based on the activity of 11 GPs covering a population of 100 000 habitants (the Ajaccio area in the southwest of Corsica; see Figure 1) and responding to private house calls 24 h a day, 7 days a week [8]. </plain></SENT>
<SENT sid="23982" pm="."><plain>The GPs report on a daily basis the sociodemographic and medical data for each patient visited (age, sex, diagnosis and hospitalization) [20]. </plain></SENT>
<SENT sid="23983" pm="."><plain>For maximal comparability with respect to the definition of the French Sentinelles network for the inclusion of ILI patients, the SOS Médecins ILI definition (sudden fever of 38.5°C or above, respiratory symptoms and myalgia) is coded according to the International Classification of Primary Care (code “R80 Influenza/R80 ILI) [20]. </plain></SENT>
<SENT sid="23984" pm="."><plain>The weekly number of visits coded as “R80 Influenza/R80 ILI” by SOS Médecins, was analyzed. </plain></SENT>
<SENT sid="23985" pm="."><plain>The chosen indicator of ILI activity was the number of ILIs coded per week divided by the total number of visits coded per week. </plain></SENT>
</text></p></sec><sec id="s2e"><title><text><SENT sid="23986" pm="."><plain>Hospital Emergency Units: The OSCOUR Network </plain></SENT>
</text></title><p><text><SENT sid="23987" pm="."><plain>In Corsica, the OSCOUR network has been based since 2011–2012 on the activity of the two hospitals located in the northeast (Bastia) and southeast (Porto-Vecchio) of Corsica (Figure 1). </plain></SENT>
<SENT sid="23988" pm="."><plain>Data (age, sex, diagnosis and hospitalization) were collected directly from outpatients' computerized medical files completed during medical consultations and transmitted encrypted to the InVS 7 days a week. </plain></SENT>
<SENT sid="23989" pm="."><plain>Information about patients with a diagnosis of influenza (International Classification of Diseases-10: J09 to J11) was extracted weekly. </plain></SENT>
<SENT sid="23990" pm="."><plain>The J09 code corresponds to influenza due to A(H1N1)pdm2009, J10 corresponds to influenza caused by other identified influenza viruses, and J11 corresponds to an ILI caused by unidentified influenza viruses. </plain></SENT>
<SENT sid="23991" pm="."><plain>The indicator chosen was the number of cases coded J09 to J11 per week divided by the total number of visits coded per week. </plain></SENT>
</text></p></sec><sec id="s2f"><title><text><SENT sid="23992" pm="."><plain>Surveillance of Severe Influenza Cases in Intensive Care Units (ICUs) </plain></SENT>
</text></title><p><text><SENT sid="23993" pm="."><plain>Clinicians are required to report all probable and confirmed influenza cases admitted to an ICU to the regional office of the InVS (cellules de l'InVS en region), using a standardized notification form. </plain></SENT>
<SENT sid="23994" pm="."><plain>Patient information, including demographic characteristics, symptoms, risk factors for severe influenza, treatment, vaccination status, and hospitalization was collected. </plain></SENT>
<SENT sid="23995" pm="."><plain>Confirmed cases were defined as patients who tested positive for influenza by RT–PCR performed on a nasal swab. </plain></SENT>
</text></p></sec><sec id="s2g"><title><text><SENT sid="23996" pm="."><plain>Clusters of Acute Respiratory Infections (ARIs) in Nursing Homes </plain></SENT>
</text></title><p><text><SENT sid="23997" pm="."><plain>A surveillance system in nursing homes for the elderly has been implemented in Corsica since 2011–2012, to assist them in managing clusters of ARIs. </plain></SENT>
<SENT sid="23998" pm="."><plain>A cluster is defined as five cases or more within 4 days and must be reported to the local health authority using a standardized notification form. </plain></SENT>
<SENT sid="23999" pm="."><plain>An evaluation survey was conducted in July–September 2013, after the 2012–2013 ILI outbreak, providing figures about vaccination coverage (VC) against influenza for residents and for health care workers. </plain></SENT>
</text></p></sec><sec id="s2h"><title><text><SENT sid="24000" pm="."><plain>Statistical Analyses </plain></SENT>
</text></title><p><text><SENT sid="24001" pm="."><plain>The total study population was grouped into the following six age groups: 0–4, 5–14, 15–29, 30–44, 45–64, and &gt;65 years old. </plain></SENT>
<SENT sid="24002" pm="."><plain>These were chosen based on standard clinical groupings according to probable influenza exposure/risk environments. </plain></SENT>
<SENT sid="24003" pm="."><plain>For continuous variables, groups were compared by Student's t-tests or Mann–Whitney tests as appropriate. </plain></SENT>
<SENT sid="24004" pm="."><plain>The chi-squared or Fisher's exact test (as appropriate) was used to compare dichotomous variables between groups. </plain></SENT>
<SENT sid="24005" pm="."><plain>The demographic data on the Corsican population were provided by the French National Institute of Statistic and Economic Studies [21]. </plain></SENT>
</text></p><p><text><SENT sid="24006" pm="."><plain>The age-specific burden of illness was assessed using the relative illness ratio (RIR) [22]. </plain></SENT>
<SENT sid="24007" pm="."><plain>This ratio divides the contribution of a specific age group i to the total number of ILI cases  by its proportion of the general population:where Ci is the number of ILI cases in age group i (there are n age groups in total), and Ni is the total population of an age group i. RIRi helps to assess the under- or overrepresentation of age group i among ILI cases: a ratio above 1 indicates disproportionate risk. </plain></SENT>
<SENT sid="24008" pm="."><plain>Confidence intervals (CIs) were estimated with the Poisson exact method [23]. </plain></SENT>
<SENT sid="24009" pm="."><plain>Spearman rank correlation coefficients (ρ) of ILI time series were determined for the epidemic period among the surveillance networks analyzed. </plain></SENT>
<SENT sid="24010" pm="."><plain>Analyses were performed using STATA software (v. </plain></SENT>
<SENT sid="24011" pm="."><plain>11.0, StataCorp LP, Texas, USA) and R software (v. </plain></SENT>
<SENT sid="24012" pm="."><plain>2.13.2) (<ext-link ext-link-type="uri" xlink:href="http://www.r-project.org">http://www.r-project.org</ext-link>) [24]. </plain></SENT>
<SENT sid="24013" pm="."><plain>The epidemiological forms used to collect the data from ILI patients consulting the Sentinelles GPs were entered anonymously in EpiData (v. </plain></SENT>
<SENT sid="24014" pm="."><plain>1.4.2 (<ext-link ext-link-type="uri" xlink:href="http://www.epidata.dk">http://www.epidata.dk</ext-link>). </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS"><sec id="s3"><title><text><SENT sid="24015" pm="."><plain>Results </plain></SENT>
</text></title><sec id="s3a"><title><text><SENT sid="24016" pm="."><plain>Trends in ILI/Influenza </plain></SENT>
</text></title><p><text><SENT sid="24017" pm="."><plain>The ILI consultation rates are reported in Figure 2. </plain></SENT>
<SENT sid="24018" pm="."><plain>The French Sentinelles network's ILI rates indicate that the 2012–2013 epidemic in mainland France started during week 51, 2012 (from December 17 to December 23, 2012), peaked at week 5, 2013 (from January 28 to February 3, 2013), and fell below the epidemic threshold during week 11, 2013 (from March 11 to March 17, 2013). </plain></SENT>
<SENT sid="24019" pm="."><plain>All surveillance systems analyzed had a significant and strong correlation with the ILI consultation rates of the Corsican Sentinelles GPs (Figure 2) during the epidemic period. </plain></SENT>
<SENT sid="24020" pm="."><plain>The highest correlation coefficient was seen for the incidence reported by the French Sentinelles network (ρ = 0.862; p&lt;0.05), followed by the ILI rates estimated by emergency GPs in Corsica (SOS Médecins) (ρ = 0.821; p&lt;0.05) and hospital emergency units (OSCOUR) (ρ = 0.615; p&lt;0.05) (Figure 2). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0100388-g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0100388.g002</object-id><label>Figure 2</label><caption><title><text><SENT sid="24021" pm="."><plain>Temporal distribution of influenza-like illness (ILI) consultation rates from November 2012 (week 46) to April 2013 (week 14) by surveillance networks in Corsica. </plain></SENT>
</text></title><p><text><SENT sid="24022" pm="."><plain>From top to bottom, (1) Weekly rates (black line) of J09 to J11 diagnostics estimated over the totality of number of visits coded per week at hospital emergencies (OSCOUR network), (2) Weekly rates (black line) of R80 Influenza/R80 ILI diagnostics estimated over the totality of number of visits coded per week by GPs of the emergency general practice network (SOS Médecins). </plain></SENT>
<SENT sid="24023" pm="."><plain>(3) ILI incidence rates (grey line) per 100 000 inhabitants and weekly distribution of ILI samples positives (histogram bars) to at least one respiratory viruses analyzed (GPs of the Corsican Sentinelles network). </plain></SENT>
<SENT sid="24024" pm="."><plain>(4) ILI incidence rates (black line) per 100 000 inhabitants (GPs of the French Sentinelles network) and epidemic threshold (red dotted line) calculated by a periodic regression on model applied to the former observed data (Serfling'method) [44]. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0100388.g002"/></fig></SecTag></sec><sec id="s3b"><title><text><SENT sid="24025" pm="."><plain>Relative Illness Ratio (RIR) </plain></SENT>
</text></title><p><text><SENT sid="24026" pm="."><plain>The RIRs of ILI consultations by age group and surveillance system during the influenza epidemic period are shown in Figure 3. </plain></SENT>
<SENT sid="24027" pm="."><plain>Across all surveillance networks, the RIRs were consistently highest for the youngest patients (&lt;15 years old) compared with the adults. </plain></SENT>
<SENT sid="24028" pm="."><plain>The RIRs peaked for school-aged children (5–14 years old), were closer to unity for young adults (30–44 years old), and decreased for adults over 45. </plain></SENT>
<SENT sid="24029" pm="."><plain>The lowest RIRs were observed for patients aged over 65 years. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0100388-g003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0100388.g003</object-id><label>Figure 3</label><caption><title><text><SENT sid="24030" pm="."><plain>Relative Illness Ratio (RIR) by age-group for the 2012–2013 epidemic (black line) and 95% confidence intervals (CIs) (dotted line) by surveillance ILI network: (a) Corsican Sentinelles network; (b) SOS Médecins and (c) OSCOUR network. </plain></SENT>
</text></title></caption><graphic xlink:href="pone.0100388.g003"/></fig></SecTag></sec><sec id="s3c"><title><text><SENT sid="24031" pm="."><plain>Number of Severe Influenza Cases in ICUs </plain></SENT>
</text></title><p><text><SENT sid="24032" pm="."><plain>Three severe influenza cases were reported by ICU clinicians. </plain></SENT>
<SENT sid="24033" pm="."><plain>They median patient age was 62 years (min = 59, max = 66). </plain></SENT>
<SENT sid="24034" pm="."><plain>The patients had at least one risk factor for severe influenza (obesity, pulmonary pathology, or aged &gt;65 years, respectively) and had not been vaccinated with the 2012–2013 seasonal vaccine. </plain></SENT>
<SENT sid="24035" pm="."><plain>Two had laboratory-confirmed A(H1N1)pdm2009. </plain></SENT>
</text></p></sec><sec id="s3d"><title><text><SENT sid="24036" pm="."><plain>Surveillance of Outbreaks in Nursing Homes </plain></SENT>
</text></title><p><text><SENT sid="24037" pm="."><plain>Sixty-one percent (16/26) of nursing homes participated in the surveillance. </plain></SENT>
<SENT sid="24038" pm="."><plain>They were representative of all nursing homes in terms of their number of beds (p-value = 0.91), departments (p-value = 1) and their public/private status (p-value = 0.60). </plain></SENT>
<SENT sid="24039" pm="."><plain>No clusters of ARIs were declared during the 2012–2013 ILI outbreak and epidemic period by the 16 participating nursing homes. </plain></SENT>
<SENT sid="24040" pm="."><plain>The global VC of residents against seasonal 2012–2013 influenza virus was 87.6% (95% CI, (86.3%–89.0%)). </plain></SENT>
<SENT sid="24041" pm="."><plain>For the health care workers, the global VC was 16.0% (95% CI, (13.0%–18.9%)). </plain></SENT>
</text></p></sec><sec id="s3e"><title><text><SENT sid="24042" pm="."><plain>Viral Etiology </plain></SENT>
</text></title><p><text><SENT sid="24043" pm="."><plain>One hundred eighty-two nasopharyngeal samples were collected by 19 GPs of the Corsica Sentinelles network. </plain></SENT>
<SENT sid="24044" pm="."><plain>Patients' characteristics are reported in Table 2. </plain></SENT>
<SENT sid="24045" pm="."><plain>The median age of the 182 patients reported by the virology surveillance system was 30.0 years (min = 1, max = 73), and 59.3% were female. </plain></SENT>
<SENT sid="24046" pm="."><plain>Six percent of ILI patients had been vaccinated with the 2012–2013 seasonal trivalent influenza vaccine (data not shown in Table 2). </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0100388-t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0100388.t002</object-id><label>Table 2</label><caption><title><text><SENT sid="24047" pm="."><plain>Demographics of patients with influenza-like illness (ILI) enrolled by the Corsican Sentinelles network. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0100388-t002-2" xlink:href="pone.0100388.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24048" pm="."><plain>Characteristics </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24049" pm="."><plain>All ILI patients N = 182 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24050" pm="."><plain>Positives to at least one respiratory virus N = 147 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24051" pm="."><plain>Positives to one Influenza viruses N = 87 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24052" pm="."><plain>Positives to one respiratory viruses N = 43 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24053" pm="."><plain>Coinfections N = 17 </plain></SENT>
</text></td></tr></thead><tbody><tr><td colspan="6" align="left" rowspan="1"><text><SENT sid="24054" pm="."><plain>Demographic </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24055" pm="."><plain>Age -median </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24056" pm="."><plain>30 [1–73] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24057" pm="."><plain>29 [1–73] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24058" pm="."><plain>32 [1–73] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24059" pm="."><plain>18 [1–73] </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24060" pm="."><plain>16 [2]–[41] </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24061" pm="."><plain>Female sex (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24062" pm="."><plain>59.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24063" pm="."><plain>40.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24064" pm="."><plain>61.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24065" pm="."><plain>55.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24066" pm="."><plain>58.8 </plain></SENT>
</text></td></tr><tr><td colspan="6" align="left" rowspan="1"><text><SENT sid="24067" pm="."><plain>Age groups (%) </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24068" pm="."><plain>0–4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24069" pm="."><plain>12.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24070" pm="."><plain>15.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24071" pm="."><plain>15.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24072" pm="."><plain>14.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24073" pm="."><plain>17.6 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24074" pm="."><plain>5–14 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24075" pm="."><plain>18.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24076" pm="."><plain>14.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24077" pm="."><plain>15.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24078" pm="."><plain>30.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24079" pm="."><plain>29.4 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24080" pm="."><plain>15–29 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24081" pm="."><plain>18.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24082" pm="."><plain>16.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24083" pm="."><plain>14.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24084" pm="."><plain>16.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24085" pm="."><plain>29.4 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24086" pm="."><plain>30–44 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24087" pm="."><plain>26.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24088" pm="."><plain>23.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24089" pm="."><plain>30.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24090" pm="."><plain>11.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24091" pm="."><plain>23.5 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24092" pm="."><plain>45–64 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24093" pm="."><plain>18.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24094" pm="."><plain>19.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24095" pm="."><plain>24.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24096" pm="."><plain>16.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24097" pm="."><plain>0 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24098" pm="."><plain>&gt;65 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24099" pm="."><plain>5.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24100" pm="."><plain>4.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24101" pm="."><plain>22.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24102" pm="."><plain>11.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24103" pm="."><plain>0 </plain></SENT>
</text></td></tr></tbody></table></alternatives></table-wrap></SecTag><p><text><SENT sid="24104" pm="."><plain>Of the 182 samples (Table 1), 80.8% were positive for at least one virus. </plain></SENT>
<SENT sid="24105" pm="."><plain>Single infections accounted for 71.5% of patients. </plain></SENT>
<SENT sid="24106" pm="."><plain>Influenza viruses were detected in 57.7% of the patients. </plain></SENT>
<SENT sid="24107" pm="."><plain>Influenza B was detected in 30.2% of the ILI patients. </plain></SENT>
<SENT sid="24108" pm="."><plain>Influenza A was detected in 27.5% of the patients, of whom 18.1% had A(H1N1)pdm2009. </plain></SENT>
<SENT sid="24109" pm="."><plain>Coinfections were detected in 9.3% of the ILI patients. </plain></SENT>
<SENT sid="24110" pm="."><plain>The most frequent combination was an influenza B virus with one other respiratory pathogen (Table 3). </plain></SENT>
<SENT sid="24111" pm="."><plain>Patients with no infection, a single infection, or coinfection did not differ with regard to sex or clinical symptoms. </plain></SENT>
<SENT sid="24112" pm="."><plain>The distribution of the respiratory viruses among the different age groups is presented in Table 4. </plain></SENT>
<SENT sid="24113" pm="."><plain>The rate of positivity for at least one respiratory virus decreased significantly (p = 0.012). </plain></SENT>
<SENT sid="24114" pm="."><plain>Coinfections were only detected in patients less than 45 years old. </plain></SENT>
</text></p><SecTag type="TABLE"><table-wrap id="pone-0100388-t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0100388.t003</object-id><label>Table 3</label><caption><title><text><SENT sid="24115" pm="."><plain>Coinfections of respiratory viruses in patients with influenza-like illness patients enrolled by the Corsican Sentinelles network. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0100388-t003-3" xlink:href="pone.0100388.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24116" pm="."><plain>Co-infections </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24117" pm="."><plain>N </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24118" pm="."><plain>Influenza B, Influenza A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24119" pm="."><plain>1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24120" pm="."><plain>Influenza B, HAdV </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24121" pm="."><plain>3 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24122" pm="."><plain>Influenza B, HBoV </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24123" pm="."><plain>2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24124" pm="."><plain>Influenza B, HRV </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24125" pm="."><plain>1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24126" pm="."><plain>Influenza B, HRSV </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24127" pm="."><plain>2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24128" pm="."><plain>Influenza B, A(H1N1)pdm2009 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24129" pm="."><plain>1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24130" pm="."><plain>A (H1N1)pdm2009, HAdV </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24131" pm="."><plain>1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24132" pm="."><plain>A (H1N1)pdm2009, HBoV </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24133" pm="."><plain>2 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24134" pm="."><plain>A (H1N1)pdm2009,HMPV </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24135" pm="."><plain>1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24136" pm="."><plain>A (H1N1)pdm2009, HRSV </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24137" pm="."><plain>1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24138" pm="."><plain>A(H3N2), HRSV </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24139" pm="."><plain>1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24140" pm="."><plain>HRSV, HAdV </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24141" pm="."><plain>1 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24142" pm="."><plain>Total N (% of 182) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24143" pm="."><plain>17 of 182 (9.3%) </plain></SENT>
</text></td></tr></tbody></table></alternatives></table-wrap></SecTag><SecTag type="TABLE"><table-wrap id="pone-0100388-t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0100388.t004</object-id><label>Table 4</label><caption><title><text><SENT sid="24144" pm="."><plain>Distribution of viral etiologies according to age group in patients with influenza-like illness enrolled by the Corsican Sentinelles network. </plain></SENT>
</text></title></caption><alternatives><graphic id="pone-0100388-t004-4" xlink:href="pone.0100388.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24145" pm="."><plain>Age groups (%) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24146" pm="."><plain>0–4 N = 22 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24147" pm="."><plain>5–14 N = 33 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24148" pm="."><plain>15–29 N = 34 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24149" pm="."><plain>30–44 N = 49 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24150" pm="."><plain>45–64 N = 34 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24151" pm="."><plain>&gt;65 N = 10 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24152" pm="."><plain>Pvalue </plain></SENT>
</text></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24153" pm="."><plain>Positive (any type) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24154" pm="."><plain>100 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24155" pm="."><plain>93.9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24156" pm="."><plain>70.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24157" pm="."><plain>71.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24158" pm="."><plain>82.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24159" pm="."><plain>70.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24160" pm="."><plain>0.012 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24161" pm="."><plain>At least one Influenza virus </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24162" pm="."><plain>72.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24163" pm="."><plain>51.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24164" pm="."><plain>50.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24165" pm="."><plain>61.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24166" pm="."><plain>61.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24167" pm="."><plain>20.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24168" pm="."><plain>0.090 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24169" pm="."><plain>Influenza A </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24170" pm="."><plain>40.9 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24171" pm="."><plain>18.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24172" pm="."><plain>29.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24173" pm="."><plain>30.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24174" pm="."><plain>23.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24175" pm="."><plain>10.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24176" pm="."><plain>0.385 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24177" pm="."><plain>Influenza B </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24178" pm="."><plain>36.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24179" pm="."><plain>30.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24180" pm="."><plain>20.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24181" pm="."><plain>32.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24182" pm="."><plain>38.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24183" pm="."><plain>10.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24184" pm="."><plain>0.431 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24185" pm="."><plain>At least one other viruses than Influenza </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24186" pm="."><plain>36.4 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24187" pm="."><plain>54.5 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24188" pm="."><plain>35.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24189" pm="."><plain>16.3 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24190" pm="."><plain>20.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24191" pm="."><plain>50.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24192" pm="."><plain>0.004 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24193" pm="."><plain>Coinfections </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24194" pm="."><plain>13.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24195" pm="."><plain>15.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24196" pm="."><plain>14.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24197" pm="."><plain>8.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24198" pm="."><plain>0.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24199" pm="."><plain>0.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24200" pm="."><plain>0.122 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24201" pm="."><plain>HRSV (A/B) </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24202" pm="."><plain>9.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24203" pm="."><plain>24.2 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24204" pm="."><plain>14.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24205" pm="."><plain>2.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24206" pm="."><plain>14.7 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24207" pm="."><plain>0.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24208" pm="."><plain>0.040 </plain></SENT>
</text></td></tr><tr><td align="left" rowspan="1" colspan="1"><text><SENT sid="24209" pm="."><plain>HRV </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24210" pm="."><plain>13.6 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24211" pm="."><plain>9.1 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24212" pm="."><plain>5.8 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24213" pm="."><plain>0.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24214" pm="."><plain>0.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24215" pm="."><plain>40.0 </plain></SENT>
</text></td><td align="left" rowspan="1" colspan="1"><text><SENT sid="24216" pm="."><plain>0.000 </plain></SENT>
</text></td></tr></tbody></table></alternatives></table-wrap></SecTag></sec><sec id="s3f"><title><text><SENT sid="24217" pm="."><plain>Phylogenetic Analyses of Influenza Viruses </plain></SENT>
</text></title><p><text><SENT sid="24218" pm="."><plain>Among the 33 samples of A(H1N1)pdm2009 influenza virus detected in 2012–2013, 54.5% (N = 18) were randomly selected, and their HA sequences were compared with those of vaccine and reference strains for phylogenetic analysis (Figure 4; Table S1). </plain></SENT>
<SENT sid="24219" pm="."><plain>The A(H1N1)pdm2009 viruses clustered within genetic groups 6 and 7, which were characterized by the D97N and S185T (antigenic site B) mutations with respect to A/California/7/2009 (2012–2013 vaccine influenza strain). </plain></SENT>
<SENT sid="24220" pm="."><plain>Group 6 was characterized by the additional mutation D163I (antigenic site D), and group 7 by the mutations S143G (antigenic site A) and A197T, with respect to A/California/7/2009. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0100388-g004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0100388.g004</object-id><label>Figure 4</label><caption><title><text><SENT sid="24221" pm="."><plain>Evolutionary relationship of A(H1N1)pdm2009 influenza viruses sampled in Corsica during the 2012–2013 influenza like-illness outbreak. </plain></SENT>
</text></title><p><text><SENT sid="24222" pm="."><plain>The evolutionary history was inferred using the Neighbor-Joining method. </plain></SENT>
<SENT sid="24223" pm="."><plain>The bootstrap consensus tree inferred from 1000 replicates is taken to represent the evolutionary history of the taxa analyzed. </plain></SENT>
<SENT sid="24224" pm="."><plain>Branches corresponding to partitions reproduced in less than 50% bootstrap replicates are collapsed. </plain></SENT>
<SENT sid="24225" pm="."><plain>The analysis involved 79 sequences. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0100388.g004"/></fig></SecTag><p><text><SENT sid="24226" pm="."><plain>The HA of 10 of 13 (77.0%) randomly selected Corsican A(H3N2) influenza strains obtained during the 2012–2013 influenza outbreak clustered in the A/Hong Kong/3869/2011-like group 3C (Figure 5; Table S2). </plain></SENT>
<SENT sid="24227" pm="."><plain>The group 3C strains are characterized by the mutations T128A (antigenic site B), R142G (antigenic site A), and N278K (antigenic site C) with respect to A/Victoria/361/2011 (reference vaccine strain for 2012–2013). </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0100388-g005" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0100388.g005</object-id><label>Figure 5</label><caption><title><text><SENT sid="24228" pm="."><plain>Evolutionary relationship of A(H3N2) influenza viruses sampled in Corsica during the 2012–2013 influenza like-illness outbreak. </plain></SENT>
</text></title><p><text><SENT sid="24229" pm="."><plain>The evolutionary history was inferred using the Neighbor-Joining method. </plain></SENT>
<SENT sid="24230" pm="."><plain>The bootstrap consensus tree inferred from 1000 replicates is taken to represent the evolutionary history of the taxa analyzed. </plain></SENT>
<SENT sid="24231" pm="."><plain>Branches corresponding to partitions reproduced in less than 50% bootstrap replicates are collapsed. </plain></SENT>
<SENT sid="24232" pm="."><plain>The analysis involved 50 sequences. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0100388.g005"/></fig></SecTag><p><text><SENT sid="24233" pm="."><plain>The HA of 19 of 55 (34.5%) randomly selected influenza B viruses detected in 2012–2013 was compared with vaccine and reference strains for phylogenetic analysis (Figure 6; Table S3). </plain></SENT>
<SENT sid="24234" pm="."><plain>All influenza B viruses isolated in Corsica during 2012–2013 were of the Yamagata lineage and fell into genetic group 2 (95%; N = 18) and group 3 (5%; N = 1). </plain></SENT>
<SENT sid="24235" pm="."><plain>The strains belonging to group 2 were characterized by the mutations R48K (antigenic site C), P108A and I150S (antigenic site A), Y165N (antigenic site B), T181A (antigenic site D), and D229G (antigenic site D) with respect to the B/Wisconsin/1/2010 vaccine strain of the 2012–2013 season. </plain></SENT>
<SENT sid="24236" pm="."><plain>The influenza B strain belonging to group 3 was characterized by the mutations N116K (antigenic site C), K298E, and E312K. </plain></SENT>
</text></p><SecTag type="FIG"><fig id="pone-0100388-g006" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0100388.g006</object-id><label>Figure 6</label><caption><title><text><SENT sid="24237" pm="."><plain>Evolutionary relationship of B influenza viruses sampled in Corsica during the 2012–2013 influenza like-illness outbreak. </plain></SENT>
</text></title><p><text><SENT sid="24238" pm="."><plain>The evolutionary history was inferred using the Neighbor-Joining method. </plain></SENT>
<SENT sid="24239" pm="."><plain>The bootstrap consensus tree inferred from 1000 replicates is taken to represent the evolutionary history of the taxa analyzed. </plain></SENT>
<SENT sid="24240" pm="."><plain>Branches corresponding to partitions reproduced in less than 50% bootstrap replicates are collapsed. </plain></SENT>
<SENT sid="24241" pm="."><plain>The analysis involved 75 sequences. </plain></SENT>
</text></p></caption><graphic xlink:href="pone.0100388.g006"/></fig></SecTag></sec></sec></SecTag><SecTag type="DISCUSS"><sec id="s4"><title><text><SENT sid="24242" pm="."><plain>Discussion </plain></SENT>
</text></title><p><text><SENT sid="24243" pm="."><plain>The ILI consultation rates reported by the Sentinelles network remain the basis of surveillance in Corsica, because the system integrates epidemiological and virological information as well as data about the molecular characterization of the influenza viruses. </plain></SENT>
<SENT sid="24244" pm="."><plain>All surveillance systems analyzed showed a strong correlation with the ILI consultation rates declared by the Corsican Sentinelles network. </plain></SENT>
<SENT sid="24245" pm="."><plain>Overall, the RIRs of consulting different medical services that participated in ILI surveillance (Sentinelles network, SOS Médecins, or OSCOUR) showed similar trends, which decreased with age. </plain></SENT>
<SENT sid="24246" pm="."><plain>Similarly, virological data from the ILI patients enrolled from the GPs of the Sentinelles network confirmed this trend, as the rate of positivity for at least one respiratory virus decreased significantly with age. </plain></SENT>
<SENT sid="24247" pm="."><plain>No clusters of ARIs were declared during the 2012–2013 ILI outbreak by the sentinel nursing homes. </plain></SENT>
</text></p><p><text><SENT sid="24248" pm="."><plain>Among the ILI patients enrolled by the Sentinelles GPs, 80.8% tested positive for at least one of the respiratory pathogens analyzed, which is a higher positivity rate than in previous reports [2],[25],[26]. </plain></SENT>
<SENT sid="24249" pm="."><plain>This result could be explained by the high specificity of the ILI case definition used in the present study [13] and the unusual length of the 2012–2013 ILI outbreak (13 weeks) [27]. </plain></SENT>
<SENT sid="24250" pm="."><plain>In this study, coinfections were detected in persons aged 44 years and younger at a rate of 9.3%, consistent with previous studies [26], [28], [29]. </plain></SENT>
<SENT sid="24251" pm="."><plain>Several studies have reported an association between viral coinfections and increased morbidity, but these remains controversial [30]. </plain></SENT>
<SENT sid="24252" pm="."><plain>In our study, all coinfections were associated with mild ILI disease. </plain></SENT>
</text></p><p><text><SENT sid="24253" pm="."><plain>In the present study, the rate of positivity for at least one respiratory virus decreased significantly with age. </plain></SENT>
<SENT sid="24254" pm="."><plain>It should be noted that while human respiratory syncytial virus (A/B), was the second most frequently detected respiratory virus after influenza in patients aged less than 15 years, in agreement with previous studies [31], HRV was the most frequently detected virus in patients aged &gt;65 years. </plain></SENT>
<SENT sid="24255" pm="."><plain>Information about the non influenza viral infections such as HRV to ILI episodes in older persons is poor, partly because of difficulties in diagnosis related to atypical presentations and low viral loads [32]–[34]. </plain></SENT>
<SENT sid="24256" pm="."><plain>Previously, it has been suggested that HRV could be the cause of exacerbations of chronic respiratory diseases and could increase morbidity rates in frail persons as, including the elderly [33]–[34]. </plain></SENT>
<SENT sid="24257" pm="."><plain>Overall, the RIR of consulting for an ILI was similar among the different surveillance networks analyzed here and decreased significantly with age. </plain></SENT>
<SENT sid="24258" pm="."><plain>Two age groups were characterized by an RIR above 1: preschool and school-aged children less than 14 years old, and working adults aged 30–44 years. </plain></SENT>
<SENT sid="24259" pm="."><plain>This peak in the 30–44-year-old group could be explained by their proximity to children as parents. </plain></SENT>
<SENT sid="24260" pm="."><plain>This trend is in accordance with the viral etiology of the epidemic, characterized by the cocirculation of A(H1N1)pdm2009 and B influenza viruses [35]. </plain></SENT>
</text></p><p><text><SENT sid="24261" pm="."><plain>In Corsica, no clusters of ARIs were declared during the 2012–2013 ILI outbreak in sentinel nursing homes. </plain></SENT>
<SENT sid="24262" pm="."><plain>This was remarkable because of the significant cocirculation of influenza A and B viruses and of other respiratory viruses. </plain></SENT>
<SENT sid="24263" pm="."><plain>This finding is likely attributable to the high VC against influenza viruses among residents, similar to the VC previously reported in French nursing homes [36], and a certain degree of cross-protection from previous exposure to influenza A(H1N1)pdm2009 [37]. </plain></SENT>
<SENT sid="24264" pm="."><plain>It could also be due to the result of better general hygiene management, as demonstrated by the rarity of clusters of gastroenteritis (N = 3) declared by the same sentinel nursing homes. </plain></SENT>
<SENT sid="24265" pm="."><plain>However, it is unlikely to have arisen through a good VC among staff, as this was low (16%), similar to staff VC levels previously reported that ranged from 10% to 50% [36]. </plain></SENT>
</text></p><p><text><SENT sid="24266" pm="."><plain>During the 2012–2013 ILI outbreak, epidemiological studies of laboratory-confirmed cases estimated a low-to-moderate vaccine effectiveness against influenza viruses [38]–[41]. </plain></SENT>
<SENT sid="24267" pm="."><plain>Phylogenetic analyses of the HA gene in Corsica showed that all influenza B viruses belonged to the Yamagata lineage. </plain></SENT>
<SENT sid="24268" pm="."><plain>Except for one strain that belonged to the group 3, all other Influenza B strains fell into genetic group 2 and were characterized by five mutations compared with the vaccine strain, located at four antigenic sites, which could suggest a drift [42]. </plain></SENT>
<SENT sid="24269" pm="."><plain>The A(H1N1)pdm2009 viruses detected in Corsica belonged to groups 6 and 7, and showed a good match with the vaccine strain [43]. </plain></SENT>
<SENT sid="24270" pm="."><plain>As previously reported, the HA sequences of A(H3N2) viruses isolated in Corsica during the 2012–2013 season [10] were characterized by seven amino acid substitutions at four antigenic sites compared with A/Victoria/361/2011 (2012–2013 vaccine strain), suggesting a drift [42]. </plain></SENT>
</text></p><p><text><SENT sid="24271" pm="."><plain>Several limitations were inherent in the surveillance systems examined in this study. </plain></SENT>
<SENT sid="24272" pm="."><plain>The monitoring of ILI, is mainly based on clinical surveillance, as the virological surveillance, for instance, was carried out by the Sentinelles network. </plain></SENT>
<SENT sid="24273" pm="."><plain>The lack of virological confirmation for the patients of the emergency general practice network (SOS Médecins), who visited the hospital emergency departments (OSCOUR) and/or in nursing homes is an important gap. </plain></SENT>
<SENT sid="24274" pm="."><plain>The evaluation of the causative agents of ILI in patients enrolled by the GPs of the Sentinelles network did not cover all possible respiratory pathogens, as other bacterial or viral pathogens that can cause ILI were not investigated. </plain></SENT>
<SENT sid="24275" pm="."><plain>It is possible that a low viral titer could not be detected by RT-–PCR. </plain></SENT>
<SENT sid="24276" pm="."><plain>Moreover, antigenic characterization of the influenza viruses that were characterized genetically was not performed. </plain></SENT>
<SENT sid="24277" pm="."><plain>Overall, the patients were enrolled using a rather specific ILI case definition (especially for the Sentinelles network and for the SOS Médecins network), excluding infected patients with atypical ILI symptom presentations, including older persons, as well as asymptomatic infections. </plain></SENT>
<SENT sid="24278" pm="."><plain>Finally, the epidemic threshold was only available for the ILI consultation rates reported by the Sentinelles GPs at a national level, which may not be adequate at a regional level with respect to the GPs Sentinelles network and with respect to the other local surveillance systems. </plain></SENT>
</text></p><p><text><SENT sid="24279" pm="."><plain>To improve ILI surveillance in Corsica, a consortium that links together the complementary regional surveillance ILI systems described here is being implemented. </plain></SENT>
<SENT sid="24280" pm="."><plain>Today, the Corsican Sentinelles network is the only network performing viral testing of ILIs in Corsica. </plain></SENT>
<SENT sid="24281" pm="."><plain>This consortium will allow the integration of the virological surveillance of more than 20 respiratory viruses with the ILI clinical surveillance of the OSCOUR network (hospital emergency units), the SOS Médecins network (emergency network of GPs), and the surveillance of ARIs in the sentinel nursing homes. </plain></SENT>
<SENT sid="24282" pm="."><plain>The integration of virological surveillance in these systems will permit the acquisition of essential information on the spread of the analyzed respiratory viruses in the island, especially influenza viruses, and about the severity of the influenza epidemics. </plain></SENT>
</text></p><p><text><SENT sid="24283" pm="."><plain>This study is noteworthy in that it is the first extensive description of the 2012–2013 ILI outbreak and the influenza epidemic in Corsica using several surveillance systems. </plain></SENT>
<SENT sid="24284" pm="."><plain>Overall, data collected from the different surveillance systems were well correlated, and they suggest that the influenza epidemic had a low impact on older persons. </plain></SENT>
</text></p></sec></SecTag><SecTag type="SUPPL"><sec sec-type="supplementary-material" id="s5"><title><text><SENT sid="24285" pm="."><plain>Supporting Information </plain></SENT>
</text></title><supplementary-material content-type="local-data" id="pone.0100388.s001"><label>Table S1</label><caption><p><text><SENT sid="24286" pm="."><plain>Amino acid substitutions observed in antigenic sites (A–E) of the hemagglutinin protein of 19 A(H1N1)2009 influenza viruses isolated between November 2012 to April 2013 in Corsica Island, France. </plain></SENT>
</text></p><p><text><SENT sid="24287" pm="."><plain>(DOCX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0100388.s001.docx"><caption><p><text><SENT sid="24288" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0100388.s002"><label>Table S2</label><caption><p><text><SENT sid="24289" pm="."><plain>Amino acid substitutions observed in antigenic sites (A–E) of the hemagglutinin protein of 10 A(H3N2) influenza viruses isolated between November and April 2013 in Corsica Island, France. </plain></SENT>
</text></p><p><text><SENT sid="24290" pm="."><plain>(DOCX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0100388.s002.docx"><caption><p><text><SENT sid="24291" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0100388.s003"><label>Table S3</label><caption><p><text><SENT sid="24292" pm="."><plain>Amino acid substitutions observed in antigenic sites (A–E) of the hemagglutinin protein of 19 B influenza viruses isolated between November 2012 and April 2013 in Corsica Island, France. </plain></SENT>
</text></p><p><text><SENT sid="24293" pm="."><plain>(DOCX) </plain></SENT>
</text></p></caption><media xlink:href="pone.0100388.s003.docx"><caption><p><text><SENT sid="24294" pm="."><plain>Click here for additional data file. </plain></SENT>
</text></p></caption></media></supplementary-material></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="24295" pm="."><plain>We thank the GPs of the Corsican Sentinelles network, the GPs of the SOS Médecin network the intensive care units and the emergency unit of OSCOUR network for their participation to ILI surveillance in Corsica. </plain></SENT>
</text></text4fund></p></ack></SecTag><SecTag type="REF"><ref-list><title>References</title><ref id="pone.0100388-Horm1"><text><SENT sid="24296" pm="."><plain>1 HormSV, SornS, AllalL, BuchyP (2013) Influenza A(H5N1) virus surveillance at live poultry markets, Cambodia, 2011. Emerg Infect Dis 19: 305–308.23347451 </plain></SENT>
</text></ref><ref id="pone.0100388-Nakoune1"><text><SENT sid="24297" pm="."><plain>2 NakouneE, TricouV, ManirakizaA, KomoyoF, SelekonB, et al (2013) First introduction of pandemic influenza A/H1N1 and detection of respiratory viruses in pediatric patients in Central African Republic. Virol J 10: 49.23391188 </plain></SENT>
</text></ref><ref id="pone.0100388-1"><text><SENT sid="24298" pm="."><plain>3 Global influenza surveillance network:laboratory surveillance and response to pandemic H1N1 2009. Wkly Epidemiol Rec 84: 361–365.19764123 </plain></SENT>
</text></ref><ref id="pone.0100388-ECDC1"><text><SENT sid="24299" pm="."><plain>4ECDC website. </plain></SENT>
<SENT sid="24300" pm="."><plain>Available: <ext-link ext-link-type="uri" xlink:href="http://ecdc.europa.eu/en/activities/surveillance/eisn/surveillance/pages/surveillance.aspx">http://ecdc.europa.eu/en/activities/surveillance/eisn/surveillance/pages/surveillance.aspx</ext-link>. </plain></SENT>
<SENT sid="24301" pm="."><plain>Accessed 2013 December </plain></SENT>
</text></ref><ref id="pone.0100388-WHO1"><text><SENT sid="24302" pm="."><plain>5WHO website. </plain></SENT>
<SENT sid="24303" pm="."><plain>Available: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/influenza/surveillance_monitoring/en/">http://www.who.int/influenza/surveillance_monitoring/en/</ext-link>. </plain></SENT>
<SENT sid="24304" pm="."><plain>Accessed 2013 December. </plain></SENT>
</text></ref><ref id="pone.0100388-Valleron1"><text><SENT sid="24305" pm="."><plain>6 ValleronAJ, BouvetE, GarnerinP, MenaresJ, HeardI, et al (1986) A computer network for the surveillance of communicable diseases: the French experiment. Am J Public Health 76: 1289–1292.3766824 </plain></SENT>
</text></ref><ref id="pone.0100388-Josseran1"><text><SENT sid="24306" pm="."><plain>7 JosseranL, NicolauJ, CaillereN, AstagneauP, BruckerG (2006) Syndromic surveillance based on emergency department activity and crude mortality: two examples. Euro Surveill 11: 225–229.17370967 </plain></SENT>
</text></ref><ref id="pone.0100388-Gault1"><text><SENT sid="24307" pm="."><plain>8 GaultG, LarrieuS, DurandC, JosseranL, JouvesB, et al (2009) Performance of a syndromic system for influenza based on the activity of general practitioners, France. J Public Health (Oxf) 31: 286–292.19269992 </plain></SENT>
</text></ref><ref id="pone.0100388-Falchi1"><text><SENT sid="24308" pm="."><plain>9 FalchiA, AmorosJP, ArenaC, ArrighiJ, CasabiancaF, et al (2011) Genetic structure of human A/H1N1 and A/H3N2 influenza virus on Corsica Island: phylogenetic analysis and vaccine strain match, 2006–2010. PLoS One 6: e24471.21935413 </plain></SENT>
</text></ref><ref id="pone.0100388-Fantoni1"><text><SENT sid="24309" pm="."><plain>10Fantoni A, Arena C, Corrias L, Salez N, de Lamballerie XN, et al.. </plain></SENT>
<SENT sid="24310" pm="."><plain>(2013) Genetic drift of influenza A(H3N2) viruses during two consecutive seasons in 2011–2013 in Corsica, France. </plain></SENT>
<SENT sid="24311" pm="."><plain>Journal of medical virology. </plain></SENT>
</text></ref><ref id="pone.0100388-Flahault1"><text><SENT sid="24312" pm="."><plain>11 FlahaultA, BlanchonT, DorleansY, ToubianaL, VibertJF, et al (2006) Virtual surveillance of communicable diseases: a 20-year experience in France. Stat Methods Med Res 15: 413–421.17089946 </plain></SENT>
</text></ref><ref id="pone.0100388-Costagliola1"><text><SENT sid="24313" pm="."><plain>12 CostagliolaD, FlahaultA, GalinecD, GarnerinP, MenaresJ, et al (1991) A routine tool for detection and assessment of epidemics of influenza-like syndromes in France. Am J Public Health 81: 97–99.1983924 </plain></SENT>
</text></ref><ref id="pone.0100388-Carrat1"><text><SENT sid="24314" pm="."><plain>13 CarratF, TachetA, RouziouxC, HoussetB, ValleronAJ (1999) Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France. Clin Infect Dis 28: 283–290.10064245 </plain></SENT>
</text></ref><ref id="pone.0100388-Falchi2"><text><SENT sid="24315" pm="."><plain>14 FalchiA, ArenaC, AndreolettiL, JacquesJ, LevequeN, et al (2008) Dual infections by influenza A/H3N2 and B viruses and by influenza A/H3N2 and A/H1N1 viruses during winter 2007, Corsica Island, France. J Clin Virol 41: 148–151.18069055 </plain></SENT>
</text></ref><ref id="pone.0100388-Thiberville1"><text><SENT sid="24316" pm="."><plain>15 ThibervilleSD, NinoveL, Vu HaiV, Botelho-NeversE, GazinC, et al (2012) The viral etiology of an influenza-like illness during the 2009 pandemic. Journal of medical virology 84: 1071–1079.22585724 </plain></SENT>
</text></ref><ref id="pone.0100388-Gandhi1"><text><SENT sid="24317" pm="."><plain>16 GandhiA, WalshEE, FormicaMA, HennesseyPA, CriddleMM, et al (2012) Factors associated with symptomatic rhinovirus infection in patients with COPD. J Clin Virol 55: 343–347.22999488 </plain></SENT>
</text></ref><ref id="pone.0100388-Venter1"><text><SENT sid="24318" pm="."><plain>17 VenterM, NaidooD, PretoriusM, BuysA, McAnerneyJ, et al (2012) Evolutionary dynamics of 2009 pandemic influenza A virus subtype H1N1 in South Africa during 2009-2010. J Infect Dis 206 Suppl 1S166–172.23169965 </plain></SENT>
</text></ref><ref id="pone.0100388-Byarugaba1"><text><SENT sid="24319" pm="."><plain>18 ByarugabaDK, ErimaB, MillardM, KibuukaH, LL, etal (2013) Genetic analysis of influenza B viruses isolated in Uganda during the 2009-2010 seasons. Virol J 10: 11.23289789 </plain></SENT>
</text></ref><ref id="pone.0100388-Tamura1"><text><SENT sid="24320" pm="."><plain>19 TamuraK, PetersonD, PetersonN, StecherG, NeiM, et al (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731–2739.21546353 </plain></SENT>
</text></ref><ref id="pone.0100388-Bentsen1"><text><SENT sid="24321" pm="."><plain>20 BentsenBG (1986) International classification of primary care. Scand J Prim Health Care 4: 43–50.3961309 </plain></SENT>
</text></ref><ref id="pone.0100388-INSEE1"><text><SENT sid="24322" pm="."><plain>21INSEE website. </plain></SENT>
<SENT sid="24323" pm="."><plain>Available: <ext-link ext-link-type="uri" xlink:href="http://www.insee.fr/fr/publications-et-services/default.asp?page=dossiers_web/population/estimations_pop.htm#p2">http://www.insee.fr/fr/publications-et-services/default.asp?page=dossiers_web/population/estimations_pop.htm#p2</ext-link>. </plain></SENT>
<SENT sid="24324" pm="."><plain>Accessed 2014 January 14. </plain></SENT>
</text></ref><ref id="pone.0100388-Lemaitre1"><text><SENT sid="24325" pm="."><plain>22 LemaitreM, CarratF (2010) Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic. BMC Infect Dis 10: 162.20534113 </plain></SENT>
</text></ref><ref id="pone.0100388-Breslow1"><text><SENT sid="24326" pm="."><plain>23 BreslowNE, DayNE (1980) Statistical Methods in Cancer Research. The analysis of case-control studies Lyon: ARC Scientific Publications 1: 346. </plain></SENT>
</text></ref><ref id="pone.0100388-R1"><text><SENT sid="24327" pm="."><plain>24R Development Core Team (2011) A language and environment for statistical computing. </plain></SENT>
<SENT sid="24328" pm="."><plain>R Foundation for Statistical Computing, Vienna, Austria. </plain></SENT>
<SENT sid="24329" pm="."><plain>ISBN 3-900051-07-0. <ext-link ext-link-type="uri" xlink:href="http://wwwR-projectorg/">http://wwwR-projectorg/</ext-link> 2011. </plain></SENT>
</text></ref><ref id="pone.0100388-Peci1"><text><SENT sid="24330" pm="."><plain>25 PeciA, WinterAL, GubbayJB, SkowronskiDM, BalogunEI, et al (2013) Community-acquired respiratory viruses and co-infection among patients of Ontario sentinel practices, April 2009 to February 2010. Influenza Other Respi Viruses 7: 559–566. </plain></SENT>
</text></ref><ref id="pone.0100388-Huo1"><text><SENT sid="24331" pm="."><plain>26 HuoX, QinY, QiX, ZuR, TangF, et al (2012) Surveillance of 16 respiratory viruses in patients with influenza-like illness in Nanjing, China. Journal of medical virology 84: 1980–1984.23080506 </plain></SENT>
</text></ref><ref id="pone.0100388-rseau1"><text><SENT sid="24332" pm="."><plain>27réseau Sentinelles US, Inserm UMPC. </plain></SENT>
<SENT sid="24333" pm="."><plain>Annual report of activities 2011. <ext-link ext-link-type="uri" xlink:href="http://wwwsentiwebfr/2202pdf">http://wwwsentiwebfr/2202pdf</ext-link>  </plain></SENT>
</text></ref><ref id="pone.0100388-Friesema1"><text><SENT sid="24334" pm="."><plain>28 FriesemaIH, KoppeschaarCE, DonkerGA, DijkstraF, van NoortSP, et al (2009) Internet-based monitoring of influenza-like illness in the general population: experience of five influenza seasons in The Netherlands. Vaccine 27: 6353–6357.19840672 </plain></SENT>
</text></ref><ref id="pone.0100388-Ren1"><text><SENT sid="24335" pm="."><plain>29 RenL, GonzalezR, WangZ, XiangZ, WangY, et al (2009) Prevalence of human respiratory viruses in adults with acute respiratory tract infections in Beijing, 2005-2007. Clin Microbiol Infect 15: 1146–1153.19456830 </plain></SENT>
</text></ref><ref id="pone.0100388-Esper1"><text><SENT sid="24336" pm="."><plain>30 EsperFP, SpahlingerT, ZhouL (2011) Rate and influence of respiratory virus co-infection on pandemic (H1N1) influenza disease. J Infect 63: 260–266.21546090 </plain></SENT>
</text></ref><ref id="pone.0100388-Nair1"><text><SENT sid="24337" pm="."><plain>31 NairH, NokesDJ, GessnerBD, DheraniM, MadhiSA, et al (2010) Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 375: 1545–1555.20399493 </plain></SENT>
</text></ref><ref id="pone.0100388-Falsey1"><text><SENT sid="24338" pm="."><plain>32Falsey AR, McElhaney JE, Beran J, van Essen GA, Duval X, et al.. </plain></SENT>
<SENT sid="24339" pm="."><plain>(2014) Respiratory Syncytial Virus and Other Respiratory Viral Infections in Older Adults With Moderate to Severe Influenza-like Illness. </plain></SENT>
<SENT sid="24340" pm="."><plain>J Infect Dis. </plain></SENT>
</text></ref><ref id="pone.0100388-Longtin1"><text><SENT sid="24341" pm="."><plain>33 LongtinJ, WinterAL, HengD, Marchand-AustinA, EshaghiA, et al (2010) Severe human rhinovirus outbreak associated with fatalities in a long-term care facility in Ontario, Canada. J Am Geriatr Soc 58: 2036–2038. </plain></SENT>
</text></ref><ref id="pone.0100388-Hershenson1"><text><SENT sid="24342" pm="."><plain>34Hershenson MB (2010) Rhinovirus and respiratory disease. </plain></SENT>
<SENT sid="24343" pm="."><plain>E Ehrenfeld, E Domingo, RP Roos (Eds) The Picornaviruses, ASM Press, Washington, DC: pp. </plain></SENT>
<SENT sid="24344" pm="."><plain>369–382. </plain></SENT>
</text></ref><ref id="pone.0100388-Turbelin1"><text><SENT sid="24345" pm="."><plain>35 TurbelinC, SoutyC, PelatC, HanslikT, SarazinM, et al (2013) Age distribution of influenza like illness cases during post-pandemic A(H3N2): comparison with the twelve previous seasons, in France. PLoS One 8: e65919.23755294 </plain></SENT>
</text></ref><ref id="pone.0100388-Vaux1"><text><SENT sid="24346" pm="."><plain>36 VauxS, NoelD, FonteneauL, GuthmannJP, Levy-BruhlD (2010) Influenza vaccination coverage of healthcare workers and residents and their determinants in nursing homes for elderly people in France: a cross-sectional survey. BMC Public Health 10: 159.20338028 </plain></SENT>
</text></ref><ref id="pone.0100388-Hancock1"><text><SENT sid="24347" pm="."><plain>37 HancockK, VeguillaV, LuX, ZhongW, ButlerEN, et al (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945–1952.19745214 </plain></SENT>
</text></ref><ref id="pone.0100388-Guthmann1"><text><SENT sid="24348" pm="."><plain>38 GuthmannJP, FonteneauL, BonmarinI, Levy-BruhlD (2012) Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010–2011. Vaccine 30: 995–997.22178520 </plain></SENT>
</text></ref><ref id="pone.0100388-Kelvin1"><text><SENT sid="24349" pm="."><plain>39 KelvinDJ, FarooquiA (2013) Extremely low vaccine effectiveness against influenza H3N2 in the elderly during the 2012/2013 flu season. J Infect Dev Ctries 7: 299–301.23493013 </plain></SENT>
</text></ref><ref id="pone.0100388-Kissling1"><text><SENT sid="24350" pm="."><plain>40Kissling E, Valenciano M, Larrauri A, Oroszi B, Cohen J, et al. </plain></SENT>
<SENT sid="24351" pm="."><plain>(2013) Low and decreasing vaccine effectiveness against influenza A(H3) in 2011/12 among vaccination target groups in Europe: results from the I-MOVE multicentre case-control study. </plain></SENT>
<SENT sid="24352" pm="."><plain>Euro Surveill 18.. </plain></SENT>
</text></ref><ref id="pone.0100388-Bragstad1"><text><SENT sid="24353" pm="."><plain>41Bragstad K, Emborg H, Kolsen Fischer T, Voldstedlund M, Gubbels S, et al. </plain></SENT>
<SENT sid="24354" pm="."><plain>(2013) Low vaccine effectiveness against influenza A(H3N2) virus among elderly people in Denmark in 2012/13 - a rapid epidemiological and virological assessment. </plain></SENT>
<SENT sid="24355" pm="."><plain>Euro Surveill 18.. </plain></SENT>
</text></ref><ref id="pone.0100388-Wilson1"><text><SENT sid="24356" pm="."><plain>42 WilsonIA, CoxNJ (1990) Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol 8: 737–771.2188678 </plain></SENT>
</text></ref><ref id="pone.0100388-ECDC2"><text><SENT sid="24357" pm="."><plain>43ECDC (2013) Influenza virus characterisation. </plain></SENT>
<SENT sid="24358" pm="."><plain>Summary report September 2013. </plain></SENT>
<SENT sid="24359" pm="."><plain>Surveillance report. </plain></SENT>
</text></ref><ref id="pone.0100388-Costagliola2"><text><SENT sid="24360" pm="."><plain>44 CostagliolaD (1994) When is the epidemic warning cut-off point exceeded? Eur J Epidemiol 10: 475–476.7843360 </plain></SENT>
</text></ref></ref-list></SecTag></back></article>
